|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.770 USD | -1.42% |
|
+6.54% | -6.10% |
| Market Cap | 22.14M 19.39M 17.86M 16.58M 31.48M 2.11B 31.9M 214M 83.19M 1.04B 83.13M 81.31M 3.59B | P/E 2026 * |
-1.35x | P/E 2027 * | -1.73x |
|---|---|---|---|---|---|
| Enterprise Value | 22.14M 19.39M 17.86M 16.58M 31.48M 2.11B 31.9M 214M 83.19M 1.04B 83.13M 81.31M 3.59B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 3.27x |
| Free-Float |
97.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cellectar Biosciences, Inc.
| 1 day | -1.42% | ||
| 1 week | +6.54% | ||
| Current month | -0.36% | ||
| 1 month | +6.95% | ||
| 3 months | +2.21% | ||
| 6 months | -13.98% | ||
| Current year | -6.10% |
| 1 week | 2.66 |  | 3.02 |
| 1 month | 2.2 | | 3.08 |
| Current year | 2.2 | | 4.7 |
| 1 year | 2.2 | | 6.52 |
| 3 years | 2.2 | | 133.5 |
| 5 years | 2.2 | | 366 |
| 10 years | 2.2 | | 10,410.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Caruso
CEO | Chief Executive Officer | 66 | 2015-06-14 |
Chad Kolean
DFI | Director of Finance/CFO | 60 | 2014-05-27 |
Jarrod Longcor
COO | Chief Operating Officer | 52 | 2022-02-22 |
| Director | Title | Age | Since |
|---|---|---|---|
John Neis
BRD | Director/Board Member | 69 | 2008-01-31 |
James Caruso
BRD | Director/Board Member | 66 | 2015-06-14 |
Stefan Loren
BRD | Director/Board Member | 61 | 2015-06-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-06 | Buy | Chief Operating Officer | 34,720 | 1.2970% | ||
| 05-06 | Buy | Chief Executive Officer | 34,720 | 1.2970% | ||
| 12-11 | Sell | Director | 198 | 0.0074% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.42% | +6.54% | -42.29% | -95.34% | 22.14M | |
| +2.87% | -2.43% | +53.72% | +159.07% | 1,070B | |
| +2.72% | +0.32% | +66.23% | +60.48% | 624B | |
| +1.02% | +0.18% | +34.59% | +85.62% | 450B | |
| -0.03% | +0.53% | +31.00% | +25.82% | 328B | |
| +2.50% | +2.06% | +40.83% | +42.33% | 292B | |
| +1.54% | -0.06% | +29.60% | +48.98% | 284B | |
| +2.69% | +4.70% | -25.34% | -38.66% | 217B | |
| +1.92% | +1.63% | +22.87% | +64.34% | 198B | |
| +3.23% | +2.60% | +15.98% | +70.00% | 161B | |
| Average | +1.64% | +1.62% | +22.72% | +42.27% | 362.44B | |
| Weighted average by Cap. | +2.16% | +0.77% | +40.42% | +81.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.76M 5.92M 5.46M 5.07M 9.62M 645M 9.75M 65.32M 25.42M 317M 25.41M 24.85M 1.1B |
| Net income | -30.88M -27.05M -24.91M -23.12M -43.91M -2.95B -44.5M -298M -116M -1.45B -116M -113M -5.01B | -34.97M -30.63M -28.21M -26.18M -49.72M -3.34B -50.39M -338M -131M -1.64B -131M -128M -5.68B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | US$2.770 | -1.42% | 30,988 |
| 26-07-02 | US$2.810 | -0.71% | 26,242 |
| 26-07-01 | US$2.830 | +1.80% | 98,503 |
| 26-06-30 | US$2.780 | +6.92% | 415,821 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLRB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
